title: Differentiation of adipose-derived stem cells into Schwann cell phenotype induces expression of P2X receptors that control cell death.
abstract: Schwann cells (SCs) are fundamental for development, myelination and regeneration in the peripheral nervous system. Slow growth rate and difficulties in harvesting limit SC applications in regenerative medicine. Several molecules, including receptors for neurosteroids and neurotransmitters, have been suggested to be implicated in regulating physiology and regenerative potential of SCs. Adipose-derived stem cells (ASCs) can be differentiated into SC-like phenotype (dASC) sharing morphological and functional properties with SC, thus representing a valid SC alternative. We have previously shown that dASC express γ-aminobutyric-acid receptors, which modulate their proliferation and neurotrophic potential, although little is known about the role of other neurotransmitters in ASC. In this study, we investigated the expression of purinergic receptors in dASC. Using reverse transriptase (RT)-PCR, western blot analyses and immunocytochemistry, we have demonstrated that ASCs express P2X3, P2X4 and P2X7 purinoceptors. Differentiation of ASCs towards glial phenotype was accompanied by upregulation of P2X4 and P2X7 receptors. Using Ca(2+)-imaging techniques, we have shown that stimulation of purinoceptors with adenosine 5'-triphosphate (ATP) triggers intracellular Ca(2+) signals, indicating functional activity of these receptors. Whole-cell voltage clamp recordings showed that ATP and BzATP induced ion currents that can be fully inhibited with specific P2X7 antagonists. Finally, using cytotoxicity assays we have shown that the increase of intracellular Ca(2+) leads to dASC death, an effect that can be prevented using a specific P2X7 antagonist. Altogether, these results show, for the first time, the presence of functional P2X7 receptors in dASC and their link with critical physiological processes such as cell death and survival. The presence of these novel pharmacological targets in dASC might open new opportunities for the management of cell survival and neurotrophic potential in tissue engineering approaches using dASC for nerve repair.
authors.affiliation: Faculty of Medical and Human Sciences, The University of Manchester, Manchester, UK. alessandro.faroni@manchester.ac.uk
authors.forename: A
authors.initials: A
authors.lastname: Faroni
authors.forename: S W
authors.initials: SW
authors.lastname: Rothwell
authors.forename: A A
authors.initials: AA
authors.lastname: Grolla
authors.forename: G
authors.initials: G
authors.lastname: Terenghi
authors.forename: V
authors.initials: V
authors.lastname: Magnaghi
authors.forename: A
authors.initials: A
authors.lastname: Verkhratsky
mesh_terms: D017667:Adipocytes / Q000166:cytology / Q000187:drug effects*; D016923:Cell Death / Q000187:drug effects; D002454:Cell Differentiation; D006801:Humans; D010641:Phenotype; D058469:Receptors, Purinergic P2X / Q000378:metabolism*; D012583:Schwann Cells / Q000166:cytology / Q000378:metabolism*; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects*; D016019:Survival Analysis; D015854:Up-Regulation
chemical_list: D058469:Receptors, Purinergic P2X